Recognition of children with sickle cell disease in the Netherlands;Herkenning van kinderen met sikkelcelziekte in Nederland

Nederlands Tijdschrift voor Geneeskunde

Volumn 151, Issue 45, 2007, Pages 2498-2501

  Heijboer, H ^a   Van Den Tweel, X W ^a   Fijnvandraat, K ^a   Peters, M ^a  

^a EMMA CHILDREN S HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADOPTED CHILD; HEALTH PROGRAM; HUMAN; IMMIGRANT; JAUNDICE; NETHERLANDS; NEWBORN SCREENING; PALLOR; REVIEW; RISK ASSESSMENT; SICKLE CELL ANEMIA; STREPTOCOCCUS INFECTION; SYMPTOMATOLOGY;

ANEMIA, SICKLE CELL; DIAGNOSIS, DIFFERENTIAL; HOSPITALS, PEDIATRIC; HUMANS; INFANT, NEWBORN; NEONATAL SCREENING; NETHERLANDS; SICKLE CELL TRAIT;

EID: 36248981966     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (14)

1. Leikin SL, Gallagher D, Kinney TR, Sloane D, Klug P, Rida W. Mortality in children and adolescents with sickle cell disease. Cooperative Study of Sickle Cell Disease. Pediatrics. 1989;84:500-8.
2. Gaston MH, Verter JI, Woods G, Pegelow C, Kelleher J, Presbury G, et al. Prophylaxis with oral penicillin in children with sickle cell anemia. A randomized trial. N Engl J Med. 1986;314:1593-9.
3. Vichinsky E, Hurst D, Earles A, Kleman K, Lubin B. Newborn screening for sickle cell disease: effect on mortality. Pediatrics. 1988;81:749-55.
4. Lee A, Thomas P, Cupidore L, Serjeant B, Serjeant G. Improved survival in homozygous sickle cell disease: lessons from a cohort study. BMJ. 1995;311:1600-2.
5. Tweel XW van den, Heijboer H, Fijnvandraat K, Peters M. Identifying children with sickle cell anaemia in a non-endemic country: age at diagnosis and presenting symptoms. Eur J Pediatr. 2006;165:581-2.
6. Bainbridge R, Higgs DR, Maude GH, Serjeant GR. Clinical presentation of homozygous sickle cell disease. J Pediatr. 1985;106:881-5.
7. El Mouzan MI, al Awamy BH, al Torki MT. Clinical features of sickle cell disease in eastern Saudi Arab children. Am J Pediatr Hematol Oncol. 1990;12:51-5.
8. Al Sheyyab M, Rimawi H, Izzat M, Batieha A, el Bashir N, Almasri N, et al. Sickle cell anaemia in Jordan and its clinical patterns. Ann Trop Paediatr. 1996;16:249-53.
9. Williams S, Maude GH, Serjeant GR. Clinical presentation of sickle cell-hemoglobin C disease. J Pediatr. 1986;109:586-9.
10. Gill FM, Sleeper LA, Weiner SJ, Brown AK, Bellevue R, Grover R, et al. Clinical events in the first decade in a cohort of infants with sickle cell disease. Cooperative Study of Sickle Cell Disease. Blood. 1995;86:776-83.
11. Higgs DR, Aldridge BE, Lamb J, Clegg JB, Weatherall DJ, Hayes RJ, et al. The interaction of alpha-thalassemia and homozygous sickle-cell disease. N Engl J Med. 1982;306:1441-6.
12. Neonato MG, Guilloud-Bataille M, Beauvais P, Bégué P, Belloy M, Benkerrou M, et al. Acute clinical events in 299 homozygous sickle cell patients living in France. French Study Group on Sickle Cell Disease. Eur J Haematol. 2000;65:155-64.
13. Ohene-Frempohg K, Weiner SJ, Sleeper LA, Miller ST, Embury S, Moohr JW, et al. Cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood. 1998;91:288-94.
14. Powars DR, Chan L, Schroeder WA. Beta S-gene-cluster haplotypes in sickle cell anemia: clinical implications. Am J Pediatr Hematol Oncol. 1990;12:367-74.